Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy

Few studies have investigated sustained B-cell depletion after long-term intravenous (IV) anti-CD20 B-cell depleting therapy (BCDT) in multiple sclerosis (MS) with respect to strict and/or minimal disease activity. The main objective of this study was to investigate how sustained B-cell depletion af...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Sean A., Lemarchant, Bruno, Alberto, Tifanie, Boucher, Julie, Outteryck, Olivier, Labalette, Myriam, Rogeau, Stéphanie, Dubucquoi, Sylvain, Zéphir, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684468/
https://www.ncbi.nlm.nih.gov/pubmed/37882961
http://dx.doi.org/10.1007/s13311-023-01446-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684468/
https://www.ncbi.nlm.nih.gov/pubmed/37882961
http://dx.doi.org/10.1007/s13311-023-01446-5

Ejemplares similares